MDA-MB 231
Quick Actions
Documentation 0 files
Product Overview
Description
MDA-MB-231 cells are a striking example of highly invasive breast cancer cells that exhibit a mesenchymal-like phenotype. In laboratory cultures, they grow as adherent cells, forming a robust substratum that mimics their behavior in the tumor microenvironment. These cells are extensively utilized in research to gain insights into critical aspects of cancer biology, including tumor invasion and metastasis.
They serve as a valuable model for investigating the process of epithelial-to-mesenchymal transition, where cancer cells acquire migratory and invasive properties. Moreover, MDA-MB-231 cells are crucial for studying drug resistance mechanisms and deciphering various cancer signaling pathways, making them an essential tool for advancing our understanding of breast cancer and developing targeted therapies.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBP-231
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characteristics:
Species: Human
Tissue: Breast / mammary gland
Disease: Breast adenocarcinoma
Cancer subtype: Triple-negative breast cancer
Receptor status: ER-negative, PR-negative, HER2-negative
Growth type: Adherent monolayer
Morphology: Spindle-shaped / epithelial-mesenchymal-like
Quick Facts
Product Type
Tumor Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support